Bioscrip reported $231.77M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Bioscrip BIOS:US $ 231.77M 14.58M
Cigna CI:US $ 3.78B 281M
CVS Health CVS:US $ 17375M 785M
Davita Healthcare Partners DVA:US $ 109.52M 1.8M
HCA HCA:US $ 2043M 40M
Laboratory Of America LH:US $ 436.3M 4.4M
Quest Diagnostics DGX:US $ 187M 10M
Surmodics SRDX:US $ 10.93M 1.46M
Tenet Healthcare THC:US $ 387M 4M